-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SwT/FqAKVUknrmVOZ1Ni5ldj5xYaW48MN6thdMyrbgBFG8eovV/D/Onp42qmUHf8 RH1iiJ3LjS+c+rnUSa1SMQ== 0000919015-02-000004.txt : 20020606 0000919015-02-000004.hdr.sgml : 20020606 20020603145800 ACCESSION NUMBER: 0000919015-02-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020603 ITEM INFORMATION: Other events FILED AS OF DATE: 20020603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPHERE MEDICAL INC CENTRAL INDEX KEY: 0000919015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043216867 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23678 FILM NUMBER: 02668808 BUSINESS ADDRESS: STREET 1: 1050 HINGHAM STREET CITY: ROCKLAND STATE: MA ZIP: 02370 BUSINESS PHONE: 7816817900 MAIL ADDRESS: STREET 1: 1050 HINGHAM STREET CITY: ROCKLAND STATE: MA ZIP: 02370 FORMER COMPANY: FORMER CONFORMED NAME: BIOSEPRA INC DATE OF NAME CHANGE: 19940215 8-K 1 body60302.txt RESIGNATION OF CEO 1 ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------- FORM 8-K CURRENT REPORT -------------- PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 -------------------------------------- Date of Report (Date of earliest event reported): June 3, 2002 BIOSPHERE MEDICAL, INC. -------------------------------------------------------------- (Exact name of registrant as specified in its Charter) Delaware 0-23678 04-3216867 ------------------------- ------------ ----------------- (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 1050 Hingham St. Rockland, Massachusetts 02370 ---------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (781) 681-7900 ---------------------------------------------------- (Former Name or Former Address if Changed Since Last Report) ================================================================================ Page 1 of 3 2 ITEM 5. OTHER EVENTS. On June 3, 2002, BioSphere Medical, Inc. issued a press release (which is attached hereto as Exhibit 99) announcing that John M. Carnuccio, President and Chief Executive Officer, will resign effective September 1, 2002, to pursue other opportunities. Paul A. Looney, who has served as a director since 1994, has been appointed Chairman of the Board. Robert M. Palladino, Vice President and Chief Financial Officer, has been promoted to Executive Vice President. The Board of Directors has initiated a search for a new Chief Executive Officer. Page 2 of 3 3 SIGNATURES Pursuant to the requirements of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSPHERE MEDICAL, INC. (Registrant) Date: June 3, 2002 By: /s/ Robert M. Palladino -------------------------------- Executive Vice President and Chief Financial Officer Page 3 of 3 EX-99 3 ex99.txt PRESS RELEASE BioSphere Medical-TM- CHIEF EXECUTIVE OFFICER TO RESIGN PAUL A. LOONEY APPOINTED CHAIRMAN ROCKLAND, Mass. June 3, 2002 -- BioSphere Medical Inc. (Nasdaq: BSMD) today announced that John Carnuccio, President and Chief Executive Officer, will resign effective September 1, 2002, to pursue other opportunities. Paul A. Looney, who has served as a director since 1994, has been appointed Chairman of the Board. Robert Palladino, Vice President and Chief Financial Officer, has been promoted to Executive Vice President. The Board of Directors has initiated a search for a new Chief Executive Officer. "BioSphere Medical is entering a critical period of growth of its embolotherapy product line. As a result, the company represents an attractive opportunity for a seasoned executive," said Paul Looney. "John Carnuccio has made a valuable contribution in building an exciting and growing medical device franchise, and we wish him well in his future endeavors." About BioSphere Medical, Inc. BioSphere Medical, Inc., based in Rockland, Massachusetts, is a medical device company focused on embolotherapy, the treatment of tumors and vascular malformations by occluding their blood supply. The Company is pioneering the use of patented and proprietary bioengineered microspheres as a new class of embolics. BioSphere Medical's lead products, Embosphere(R) Microspheres and EmboGold(TM) Microspheres, have been cleared by the FDA for marketing for hypervascularized tumors and vascular malformations. The Company has filed a 510(k) application and is currently awaiting a decision by FDA on expanded labeling that would include use of Embosphere(R) Microspheres for uterine fibroid embolization (UFE) in the United States. BioSphere Medical has received CE Mark approval in the European Community and approvals in Canada and Australia which allow the Company to sell Embosphere(R) Microspheres and EmboGold(TM) Microspheres for use in general embolization procedures, including uterine fibroid embolization. For additional information about BioSphere Medical, see the Company's website at www.biospheremed.com. Contact: BioSphere Medical, Inc. Kate Rajeck, 781-681-7928 -----END PRIVACY-ENHANCED MESSAGE-----